Optiscan Receives $1.69m R&D Tax Refund
- Date and time
- Announcement type
- Periodic Reports
Show detailsHide details
- Category
- Reports
- Report codes
- 03014
- Sector
- Health Care
- Industry group
- Health Care Equipment & Services
Recent OIL announcements
- Quarterly Activities/Appendix 4C Cash Flow Report
- Optiscan Signs New Research Agreement for Breast Study
- Head and Neck Study Progressing Ahead of Schedule
- Optiscan Launches InSpecta Device for Veterinary Medicine
- Halfway Mark Reached in Optiscan Breast Cancer Study
- Second Anniversary of Optiscan and Mayo Clinic Agreement